119 related articles for article (PubMed ID: 38387259)
1. Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.
Hu J; Huang Q; Hu W; Liang F; Gao J; Yang J; Qiu X; Zhang H; Zhang G; Lu JJ; Kong L
Oral Oncol; 2024 Apr; 151():106683. PubMed ID: 38387259
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study.
Hu J; Yang Z; Gao J; Hu W; Yang J; Qiu X; Ma G; Kong L; Lu JJ
Ann Transl Med; 2022 Nov; 10(22):1196. PubMed ID: 36544650
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
6. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy.
Xiao W; Liu S; Tian Y; Guan Y; Huang S; Lin C; Zhao C; Lu T; Han F
PLoS One; 2015; 10(4):e0125351. PubMed ID: 25927527
[TBL] [Abstract][Full Text] [Related]
8. Volumetric parameters derived from FLT-PET performed at completion of treatment predict efficacy of Carbon-ion Radiotherapy in patients with locally recurrent Nasopharyngeal Carcinoma.
Hu J; Yang Z; Gao J; Hu W; Yang J; Qiu X; Zhang Y; Ma G; Kong L; Lu JJ
J Cancer; 2020; 11(23):7073-7080. PubMed ID: 33123296
[TBL] [Abstract][Full Text] [Related]
9. A protocol for a randomized trial evaluating the role of carbon-ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Hu W; Gao J; Yang J; Zhang H; Lu JJ; Kong L
Cancer Med; 2024 Feb; 13(3):e6742. PubMed ID: 38205914
[TBL] [Abstract][Full Text] [Related]
10. Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck.
Yang J; Gao J; Wu X; Hu J; Hu W; Kong L; Lu JJ
J Cancer; 2018; 9(12):2215-2223. PubMed ID: 29937942
[No Abstract] [Full Text] [Related]
11. Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
Tomizawa K; Shibuya K; Shiba S; Okazaki S; Miyasaka Y; Oishi M; Okamoto M; Ohno T
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1100-1109. PubMed ID: 36870514
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
13. Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Feng M; Wang W; Fan Z; Fu B; Li J; Zhang S; Lang J
Radiat Oncol; 2013 Sep; 8():208. PubMed ID: 24007375
[TBL] [Abstract][Full Text] [Related]
14. The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx.
Hu J; Hu W; Gao J; Yang J; Qiu X; Huang Q; Kong L; Lu JJ
Ann Transl Med; 2022 Nov; 10(22):1198. PubMed ID: 36544666
[TBL] [Abstract][Full Text] [Related]
15. The effect of primary tumor volume on the prognosis of nasopharyngeal carcinoma in era of volumetric modulated arc therapy: a propensity score matched cohort study.
Lin X; Wang B; Zheng F; Fei Z; Chen C
Braz J Otorhinolaryngol; 2023; 89(3):374-382. PubMed ID: 37105031
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Liang SB; Teng JJ; Hu XF; Yang XL; Luo M; Fang XN; Liu DS; Chen Y; Fu LW
BMC Cancer; 2017 Jul; 17(1):506. PubMed ID: 28754109
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of MRI-based late-course tumor volume in locoregionally advanced nasopharyngeal carcinoma.
Yan G; Feng Y; Wu M; Li C; Wei Y; Hua L; Zhao G; Hu Z; Yao S; Hou L; Chen X; Liu Q; Huang Q
Radiat Oncol; 2022 Jun; 17(1):111. PubMed ID: 35761414
[TBL] [Abstract][Full Text] [Related]
18. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
Dionisi F; Croci S; Giacomelli I; Cianchetti M; Caldara A; Bertolin M; Vanoni V; Pertile R; Widesott L; Farace P; Schwarz M; Amichetti M
Acta Oncol; 2019 Sep; 58(9):1238-1245. PubMed ID: 31155998
[No Abstract] [Full Text] [Related]
19. Pretreatment
Ma G; Gu B; Hu J; Kong L; Zhang J; Li Z; Xue Y; Lu J; Cao J; Cheng J; Zhang Y; Song S; Yang Z
Ann Nucl Med; 2021 Jul; 35(7):834-842. PubMed ID: 33913102
[TBL] [Abstract][Full Text] [Related]
20. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
